Miraten Uses, Dosage, Side Effects and more

Miraten Citrate belongs to the anti-cough medicines of central action. It exerts expectorant, moderate bronchodilating and anti-inflammatory action. Miraten Citrate also increases the spirometery indexes and blood oxygenation. It is safe and non-sedating which is neither chemically nor pharmacologically related to opium alkaloids. The active metabolites of Miraten Citrate have also antitussive action.

Trade Name	Miraten
Generic	Butamirate
Butamirate Other Names	Butamirate
Weight	7.5mg/5ml, 5mg/ml
Type	Syrup, Pediatric Drops
Formula	C₁₈H₂₉NO₃
Weight	Average: 307.434 Monoisotopic: 307.214743798
Groups	Experimental
Therapeutic Class	Cough suppressant
Manufacturer	Eskayef Bangladesh Ltd
Available Country	Bangladesh
Last Updated:	January 7, 2025 at 1:49 am

Uses

Miraten Citrate is used for acute cough of any etiology, suppression of pre-& post-operative cough in surgery & bronchoscopy and suppression of whooping cough.

Miraten is also used to associated treatment for these conditions: Cough

Dosage

Tablet:

Adult: 2-3 tablets daily at 8 to 12 hours intervals,
Adolescents over 12 years old: 1-2 tablets daily.

Syrup:

Children (3-6 years): 5 ml 3 times daily,
Children (6-12 years): 10 ml 3 times daily,
Adolescent: 15 ml 3 times daily,
Adult: 15 ml 4 times daily.

PediatricDrops:

Children (1-3 years): 0.75 ml 4 times daily,
Children (2 months-1 year): 0.50 ml 4 times daily.

Side Effects

Tolerance of Miraten Citrate is good. Adverse reactions such as rash, nausea, diarrhea and vertigo have been observed in a few rare cases, resolving after dose reduction or treatment withdrawal.

Precaution

Avoid simultanous administration of expectorants. Minor influence on the ability to drive & use machines. Avoid during pregnancy (1st 3 months) & lactation.

Tablet: Rare hereditary problems of galactose intolerance, Lapp lactase deficiency or glucose-galactose malabsorption.

Syrup: Sorbitol: Rare hereditary problems of fructose intolerance. Contains ethanol.

Interaction

Avoid use with expectorants.

Pregnancy & Breastfeeding use

Miraten Citrate should not be used during the first trimester of pregnancy. During the remainder of pregnancy, it can be used if indicated by a physician but with caution. As a general rule, for safety reasons, in the absence of data on elimination of the active substance in breast milk, the benefits of Miraten Citrate administration during breast feeding should be carefully weighed against the risks.

Contraindication

Miraten Citrate is contraindicated in patients with known hypersensitivity to any component of the formulation.

Acute Overdose

Accidental overdose with Miraten Citrate can cause the following symptoms: drowsiness, nausea, vomiting, diarrhea, loss of balance and hypotension. Standard emergency procedures should be followed: activated charcoal, saline laxatives and standard cardio-respiratory resuscitation.